metastasis Feb 16, 2022 Rozlytrek Studies Show Durable Responses in Patients With Brain Metastases Premium Dec 21, 2021 Biocept to Refocus CNSide Assay Plans After FDA Feedback Suggests Targeting Narrower Indications Premium Nov 17, 2021 OSE Immunotherapeutics Randomizes First Patient to Phase II Trial of Vaccine in Metastatic NSCLC Sep 2, 2021 Poseida Therapeutics Reports Early Encouraging Data for Prostate Cancer CAR T-Cell Therapy Premium Aug 16, 2021 Advanced Gastric Cancer Multiomic Analysis Reveals New Potential Therapeutic Targets Aug 9, 2021 Single Metastatic Cancer Genome Analysis Appears Sufficient to ID Biomarkers, Treatment Options Mar 31, 2021 Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay Premium Feb 16, 2021 Circulating Tumor DNA Provides Prognostic Clues in Advanced BRAF-Mutated Melanoma Cases Nov 19, 2020 Exceptional Responders Cancer Study Points to Possible Treatment Targets Premium Sep 22, 2020 Metastatic Cancer Treatment Markers Identified in Clinical WGS Study Jul 27, 2020 Eli Lilly, Zentalis Pharma Partner to Study Selective Estrogen Receptor Degrader, Verzenio Combo May 31, 2020 Oncologists Make Progress Toward Showing Utility for Brain Cancer Liquid Biopsy Apr 1, 2020 Metastatic Prostate Cancer Features Linked to Immunotherapy Response, Despite Low TMB Mar 23, 2020 Lung Cancer Brain Metastasis Genomes Marked by Recurrent Amplifications, Deletions Oct 23, 2019 Metastatic Tumor Profiles Lead to Potential Treatment Targets Sep 29, 2019 Researchers Identify Possible Methylation Signature for Brain Metastases of Lung Cancer Aug 30, 2019 Hereditary Cancer Risk Variants Found in Significant Subset of Metastatic Breast Cancer Patients Jul 15, 2019 Response to Combined Immunotherapy in Melanoma Associated With TMB, Cell-Free DNA, ctDNA May 22, 2019 Metastatic Breast Cancer Genomes Point to Distinct Features, Tumor Evolution May 6, 2019 RB1 Alterations in Advanced Prostate Cancer Associated With Poor Outcome Load More Breaking News Flare Therapeutics Raises $123M in Oversubscribed Series B Funding Round William Blair Initiates Coverage of MDxHealth With Outperform Rating White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development In Brief This Week: Fore Biotherapeutics, RayzeBio, Gilead Sciences, Atossa Therapeutics Bayer to Assess Nubeqa in High-Risk, Early-Stage Hormone-Sensitive Prostate Cancer BridgeBio Begins Phase I/II Study of SHP2 Inhibitor, Opdivo in KRAS-Mutant Solid Tumors
